Calton & Associates, Inc. Sarepta Therapeutics, Inc. Transaction History

Calton & Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$100.86 - $132.13 $162,788 - $213,257	1,614 New	1,614 $0
Q1 2021 May 03, 2021	SELL	$72.25 - $168.95 $109,531 - $256,128	-1,516 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$125.56 - $178.74 $190,348 - $270,969	1,516 New	1,516 $258,000
Q1 2020 Apr 30, 2020	SELL	$82.38 - $131.64 $133,373 - $213,125	-1,619 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$76.53 - $135.58 $123,902 - $219,504	1,619 New	1,619 $209,000

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.